Successful radioimmunotherapy of established syngeneic rat colon carcinoma with 211At-mAb.

about

Radioimmunotherapy with α-particle-emitting radionuclides.

P2860

Q34419562-8B713761-90FA-401C-884E-D9CE2FEA3BF5

P2860

Successful radioimmunotherapy of established syngeneic rat colon carcinoma with 211At-mAb.

Item

http://www.wikidata.org/entity/Q36752488

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Successful radioimmunotherapy ...... olon carcinoma with 211At-mAb.

@en

type

Item

label

Successful radioimmunotherapy ...... olon carcinoma with 211At-mAb.

@en

prefLabel

Successful radioimmunotherapy ...... olon carcinoma with 211At-mAb.

@en

P1476

Successful radioimmunotherapy ...... olon carcinoma with 211At-mAb.

@en

P2093

Erika Elgström

http://www.w3.org/2001/XMLSchema#string

Holger Jensen

http://www.w3.org/2001/XMLSchema#string

Jan Tennvall

http://www.w3.org/2001/XMLSchema#string

Rune Nilsson

http://www.w3.org/2001/XMLSchema#string

Sophie E Eriksson

http://www.w3.org/2001/XMLSchema#string

P2860

High-efficiency astatination of antibodies using N-iodosuccinimide as the oxidising agent in labelling of N-succinimidyl 3-(trimethylstannyl)benzoate.

Microdistribution of targeted, fluorescently labeled anti-carcinoembryonic antigen antibody in metastatic colorectal cancer: implications for radioimmunotherapy.

Clinical experience with alpha-particle emitting 211At: treatment of recurrent brain tumor patients with 211At-labeled chimeric antitenascin monoclonal antibody 81C6

Tumor antigen-targeted, monoclonal antibody-based immunotherapy: clinical response, cellular immunity, and immunoescape.

Antibody conjugate therapeutics: challenges and potential.

An overview of targeted alpha therapy.

A review of human cell radiosensitivity in vitro.

Radiation induced non-targeted response: mechanism and potential clinical implications.

Radioimmunotherapy and colorectal cancer.

Use of antibodies and immunoconjugates for the therapy of more accessible cancers.

P2888

2191-219x-3-23

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/2191-219X-3-23

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Tom A. Bäck

Sture Lindegren

P577

2013-04-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236112525

http://www.w3.org/2001/XMLSchema#string

P6179

1052882556

http://www.w3.org/2001/XMLSchema#string

P698

23557183

http://www.w3.org/2001/XMLSchema#string

P932

3621254

http://www.w3.org/2001/XMLSchema#string

Successful radioimmunotherapy of established syngeneic rat colon carcinoma with 211At-mAb.

about

P2860

P2860

Successful radioimmunotherapy of established syngeneic rat colon carcinoma with 211At-mAb.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P6179

P698

P932